Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FSZ32
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,829
Award facts
- Contract value 100% obligated
- $20,829.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $20,829.30 for Nexplanon 68 mg implants by the Defense Logistics Agency (DLA). This firm fixed-price contract, issued on August 22, 2025, with an ultimate completion date of September 15, 2025, represents a specific product order drawn from DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The award carries no set-aside designation, allowing the contractor to compete on its merits as a woman-owned small business. Performance will be executed at the company's location in Park Ridge, Illinois, with the pharmaceutical products ultimately supporting Department of Defense healthcare facilities.
This delivery order exemplifies the operational scope of DMS Pharmaceutical Group's primary $499,999,999 IDC with the DLA under the SPE2DB program, valid through November 2026. The parent contract enables the agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical supplies supporting military health facilities nationwide and worldwide. As a critical supplier within the federal pharmaceutical supply chain since its SAM.gov registration in 2001, DMS Pharmaceutical Group provides an extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables. The Nexplanon implant delivery order reflects the company's specialization in distributing diverse pharmaceutical products, from contraceptive devices to oncology treatments and specialty medications, directly to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FSZ32?
SPE2DB25FSZ32 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FSZ32 worth?
The government has obligated $20,829 on SPE2DB25FSZ32.
Is contract SPE2DB25FSZ32 an order under another contract?
Yes. SPE2DB25FSZ32 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FSZ32 competed?
The extent of competition for SPE2DB25FSZ32 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award